Match tier
Likely match
Presence
Current · Arkansas
Last published
2026
Sources
OpenAlex · ORCID
Refreshed
2026-10-06
Z
Zhijun Cao
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Role not yet determined Is this you? Add your title
Also affiliated: Hebei Medical University (2001); United States Food and Drug Administration (2016–2026); Guangdong Medical College (2014); Shanghai Jiao Tong University (2013–2026); University of Michigan (2007–2024); Renji Hospital (2013–2026); Soochow University (2024–2025); Third Hospital of Hebei Medical University (2001); Michigan Medicine (2007); State Key Laboratory of Oncogene and Related Genes (2018); First Affiliated Hospital of Soochow University (2021); Beijing Fengtai Hospital (2024); Fourth People's Hospital of Shenzhen (2012); State Key Laboratory of Animal Nutrition (2023–2025); China Agricultural University (2023–2025)
17 h-index
60 pubs
924 cited
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Zhijun Cao's research investigates mechanisms of disease and potential biomarkers, with a focus on drug-induced toxicities and pain modulation. He has explored the proteomic analysis of acetaminophen-induced hepatotoxicity, identifying heme oxygenase 1 as a potential plasma biomarker for liver injury. Cao has also studied the role of the anterior cingulate cortex in modulating visceral pain responses in rat models, investigating the involvement of specific receptors and vagal afferents. His work includes examining immune response proteins as predictive biomarkers for doxorubicin-induced cardiotoxicity in breast cancer patients. Cao's research has been published in peer-reviewed journals, and his metrics include an h-index of 17, with 60 total publications and 920 citations.
Metrics
- h-index: 17
- Publications: 60
- Citations: 924
Selected Publications
-
Baseline proteomic biomarkers for predicting chemotherapy-induced cardiotoxicity in breast cancer patients (2026)
-
Mass Spectrometry–Based Proteomics for Biomarker Discovery (2022)
-
Evaluating Cefoperazone-Induced Gut Metabolic Functional Changes in MR1-Deficient Mice (2022)
-
Serum metabolite profiles predict outcomes in critically ill patients receiving renal replacement therapy (2021)
-
Discovery of Novel Proteomic Biomarkers for the Prediction of Kidney Recovery from Dialysis-Dependent AKI Patients (2021)
-
Identification of Altered Proteins in the Plasma of Rats With Chronic Prostatic Inflammation Induced by Estradiol Benzoate and Sex Hormones (2021)
-
Distinct lipid signatures are identified in the plasma of rats with chronic inflammation induced by estradiol benzoate and sex hormones (2020)
-
Bile Acid Profile and its Changes in Response to Cefoperazone Treatment in MR1 Deficient Mice (2020)
-
Stability of the Human Plasma Proteome to Pre-analytical Variability as Assessed by an Aptamer-Based Approach (2019)
-
Pharmacometabolomic Pathway Response of Effective Anticancer Agents on Different Diets in Rats with Induced Mammary Tumors (2019)
-
Evaluation of the Performance of Lipidyzer Platform and Its Application in the Lipidomics Analysis in Mouse Heart and Liver (2019)
-
An Integrated Analysis of Metabolites, Peptides, and Inflammation Biomarkers for Assessment of Preanalytical Variability of Human Plasma (2019)
-
An Aptamer‐Based Approach to Assess the Human Plasma Proteome for Pre‐Analytical Variability (2018)
-
Aptamer-Based Proteomics Identifies Mortality-Associated Serum Biomarkers in Dialysis-Dependent AKI Patients (2018)
-
Immune response proteins as predictive biomarkers of doxorubicin-induced cardiotoxicity in breast cancer patients (2017)
Collaboration Network
Top Collaborators
Richard D. Beger
National Center for Toxicological Research
15 shared publications
In database
- Immune response proteins as predictive biomarkers of doxorubicin-induced cardiotoxicity in breast cancer patients
- Proteomic analysis of acetaminophen-induced hepatotoxicity and identification of heme oxygenase 1 as a potential plasma biomarker of liver injury
- Early metabolomics changes in heart and plasma during chronic doxorubicin treatment in B6C3F1 mice
- Discovery of Novel Proteomic Biomarkers for the Prediction of Kidney Recovery from Dialysis-Dependent AKI Patients
- Evaluation of the Performance of Lipidyzer Platform and Its Application in the Lipidomics Analysis in Mouse Heart and Liver
Showing 5 of 15 shared publications
Li‐Rong Yu
National Center for Toxicological Research (US)
11 shared publications
- Immune response proteins as predictive biomarkers of doxorubicin-induced cardiotoxicity in breast cancer patients
- Proteomic analysis of acetaminophen-induced hepatotoxicity and identification of heme oxygenase 1 as a potential plasma biomarker of liver injury
- Early metabolomics changes in heart and plasma during chronic doxorubicin treatment in B6C3F1 mice
- Early transcriptional changes in cardiac mitochondria during chronic doxorubicin exposure and mitigation by dexrazoxane in mice
- Discovery of Novel Proteomic Biomarkers for the Prediction of Kidney Recovery from Dialysis-Dependent AKI Patients
Showing 5 of 11 shared publications
Jinchun Sun
National Center for Toxicological Research
10 shared publications
In database
- Proteomic analysis of acetaminophen-induced hepatotoxicity and identification of heme oxygenase 1 as a potential plasma biomarker of liver injury
- Discovery of Novel Proteomic Biomarkers for the Prediction of Kidney Recovery from Dialysis-Dependent AKI Patients
- Evaluation of the Performance of Lipidyzer Platform and Its Application in the Lipidomics Analysis in Mouse Heart and Liver
- Stability of the Human Plasma Proteome to Pre-analytical Variability as Assessed by an Aptamer-Based Approach
- An Integrated Analysis of Metabolites, Peptides, and Inflammation Biomarkers for Assessment of Preanalytical Variability of Human Plasma
Showing 5 of 10 shared publications
Laura K. Schnackenberg
National Center for Toxicological Research
7 shared publications
In database
- Early metabolomics changes in heart and plasma during chronic doxorubicin treatment in B6C3F1 mice
- Discovery of Novel Proteomic Biomarkers for the Prediction of Kidney Recovery from Dialysis-Dependent AKI Patients
- Stability of the Human Plasma Proteome to Pre-analytical Variability as Assessed by an Aptamer-Based Approach
- An Integrated Analysis of Metabolites, Peptides, and Inflammation Biomarkers for Assessment of Preanalytical Variability of Human Plasma
- Aptamer-Based Proteomics Identifies Mortality-Associated Serum Biomarkers in Dialysis-Dependent AKI Patients
Showing 5 of 7 shared publications
Lisa Pence
National Center for Toxicological Research
7 shared publications
In database
- Early metabolomics changes in heart and plasma during chronic doxorubicin treatment in B6C3F1 mice
- Discovery of Novel Proteomic Biomarkers for the Prediction of Kidney Recovery from Dialysis-Dependent AKI Patients
- Stability of the Human Plasma Proteome to Pre-analytical Variability as Assessed by an Aptamer-Based Approach
- An Integrated Analysis of Metabolites, Peptides, and Inflammation Biomarkers for Assessment of Preanalytical Variability of Human Plasma
- Serum metabolite profiles predict outcomes in critically ill patients receiving renal replacement therapy
Showing 5 of 7 shared publications
Jaclyn R. Daniels
National Center for Toxicological Research
7 shared publications
In database
- Immune response proteins as predictive biomarkers of doxorubicin-induced cardiotoxicity in breast cancer patients
- Discovery of Novel Proteomic Biomarkers for the Prediction of Kidney Recovery from Dialysis-Dependent AKI Patients
- Stability of the Human Plasma Proteome to Pre-analytical Variability as Assessed by an Aptamer-Based Approach
- An Integrated Analysis of Metabolites, Peptides, and Inflammation Biomarkers for Assessment of Preanalytical Variability of Human Plasma
- Aptamer-Based Proteomics Identifies Mortality-Associated Serum Biomarkers in Dialysis-Dependent AKI Patients
Showing 5 of 7 shared publications
Thomas Schmitt
National Center for Toxicological Research (US)
4 shared publications
- Evaluation of the Performance of Lipidyzer Platform and Its Application in the Lipidomics Analysis in Mouse Heart and Liver
- Stability of the Human Plasma Proteome to Pre-analytical Variability as Assessed by an Aptamer-Based Approach
- An Integrated Analysis of Metabolites, Peptides, and Inflammation Biomarkers for Assessment of Preanalytical Variability of Human Plasma
- An Aptamer‐Based Approach to Assess the Human Plasma Proteome for Pre‐Analytical Variability
Devasmita Choudhury
Salem VA Medical Center (US)
3 shared publications
- Discovery of Novel Proteomic Biomarkers for the Prediction of Kidney Recovery from Dialysis-Dependent AKI Patients
- Aptamer-Based Proteomics Identifies Mortality-Associated Serum Biomarkers in Dialysis-Dependent AKI Patients
- Serum metabolite profiles predict outcomes in critically ill patients receiving renal replacement therapy
Paul M. Palevsky
University of Pittsburgh (US)
3 shared publications
- Discovery of Novel Proteomic Biomarkers for the Prediction of Kidney Recovery from Dialysis-Dependent AKI Patients
- Aptamer-Based Proteomics Identifies Mortality-Associated Serum Biomarkers in Dialysis-Dependent AKI Patients
- Serum metabolite profiles predict outcomes in critically ill patients receiving renal replacement therapy
Didier Portilla
University of Virginia (US)
3 shared publications
- Discovery of Novel Proteomic Biomarkers for the Prediction of Kidney Recovery from Dialysis-Dependent AKI Patients
- Aptamer-Based Proteomics Identifies Mortality-Associated Serum Biomarkers in Dialysis-Dependent AKI Patients
- Serum metabolite profiles predict outcomes in critically ill patients receiving renal replacement therapy
Beate Kamlage
Inter 3 (DE)
3 shared publications
- Stability of the Human Plasma Proteome to Pre-analytical Variability as Assessed by an Aptamer-Based Approach
- An Integrated Analysis of Metabolites, Peptides, and Inflammation Biomarkers for Assessment of Preanalytical Variability of Human Plasma
- An Aptamer‐Based Approach to Assess the Human Plasma Proteome for Pre‐Analytical Variability
Mackean P. Maisha
National Center for Toxicological Research
3 shared publications
In database
- Stability of the Human Plasma Proteome to Pre-analytical Variability as Assessed by an Aptamer-Based Approach
- An Integrated Analysis of Metabolites, Peptides, and Inflammation Biomarkers for Assessment of Preanalytical Variability of Human Plasma
- An Aptamer‐Based Approach to Assess the Human Plasma Proteome for Pre‐Analytical Variability
Vikrant Vijay
National Center for Toxicological Research
2 shared publications
In database
- Early metabolomics changes in heart and plasma during chronic doxorubicin treatment in B6C3F1 mice
- Early transcriptional changes in cardiac mitochondria during chronic doxorubicin exposure and mitigation by dexrazoxane in mice
Carrie L. Moland
National Center for Toxicological Research
2 shared publications
In database
- Early metabolomics changes in heart and plasma during chronic doxorubicin treatment in B6C3F1 mice
- Early transcriptional changes in cardiac mitochondria during chronic doxorubicin exposure and mitigation by dexrazoxane in mice
James C. Fuscoe
National Center for Toxicological Research
2 shared publications
In database
- Early metabolomics changes in heart and plasma during chronic doxorubicin treatment in B6C3F1 mice
- Early transcriptional changes in cardiac mitochondria during chronic doxorubicin exposure and mitigation by dexrazoxane in mice
Similar Researchers
Based on overlapping research topics
Jaclyn R. Daniels
National Center for Toxicological Research
Pharmacological Effects and Toxicity Studies
Metabolomics and Mass Spectrometry Techniques
Proteomics
Oksana Redko
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Disease Mechanisms Research
Neuroscience and Neuropharmacology Research
Nathan C. Twaddle
National Center for Toxicological Research
Pharmacological Effects and Toxicity Studies
Disease Mechanisms Research
Metabolomics and Mass Spectrometry Techniques
Varsha G. Desai
National Center for Toxicological Research
Pharmacological Effects and Toxicity Studies
Disease Mechanisms Research
Biomarkers
Bonnie L. Robinson
National Center for Toxicological Research
Pharmacological Effects and Toxicity Studies
Metabolomics and Mass Spectrometry Techniques
Proteomics
Alena V. Savenka
National Center for Toxicological Research
Pharmacological Effects and Toxicity Studies
Disease Mechanisms Research
Proteomics